Found: 74
Select item for more details and to access through your institution.
Impact of new direct‐acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection.
- Published in:
- Liver International, 2024, v. 44, n. 6, p. 1383, doi. 10.1111/liv.15875
- By:
- Publication type:
- Article
Visible minority status and occupation were associated with increased COVID-19 infection in Greater Vancouver British Columbia between June and November 2020: an ecological study.
- Published in:
- Frontiers in Public Health, 2024, p. 1, doi. 10.3389/fpubh.2024.1336038
- By:
- Publication type:
- Article
Risk of Severe COVID-19-Related Outcomes among Patients with Cirrhosis: A Population-Based Cohort Study in Canada.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 3, p. 351, doi. 10.3390/v16030351
- By:
- Publication type:
- Article
Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 3, p. 389, doi. 10.3390/v16030389
- By:
- Publication type:
- Article
A population‐based study of reported hepatitis C diagnoses from 1998 to 2018 in immigrants and nonimmigrants in Quebec, Canada.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 8, p. 656, doi. 10.1111/jvh.13837
- By:
- Publication type:
- Article
Use of latent class analysis and patient reported outcome measures to identify distinct long COVID phenotypes: A longitudinal cohort study.
- Published in:
- PLoS ONE, 2023, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0286588
- By:
- Publication type:
- Article
Understanding the impact of mobility on COVID-19 spread: A hybrid gravity-metapopulation model of COVID-19.
- Published in:
- PLoS Computational Biology, 2023, v. 19, n. 5, p. 1, doi. 10.1371/journal.pcbi.1011123
- By:
- Publication type:
- Article
Association of COVID-19 Infection With Incident Diabetes.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 4, p. e238866, doi. 10.1001/jamanetworkopen.2023.8866
- By:
- Publication type:
- Article
SYNDEMIC OF CHRONIC VIRAL INFECTIONS ON THE RISK OF END-STAGE RENAL DISEASE.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 245
- By:
- Publication type:
- Article
The Cascade of Care for Hepatitis C Treatment in Rwanda: A Retrospective Cohort Study of the 2017–2019 Mass Screening and Treatment Campaign.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 3, p. 661, doi. 10.3390/v15030661
- By:
- Publication type:
- Article
Clinical Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Relative to Delta in British Columbia, Canada: A Retrospective Analysis of Whole-Genome Sequenced Cases.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e18, doi. 10.1093/cid/ciac705
- By:
- Publication type:
- Article
Drug overdose and the risk of cardiovascular diseases: a nested case–control study.
- Published in:
- Clinical Research in Cardiology, 2023, v. 112, n. 2, p. 187, doi. 10.1007/s00392-021-01945-5
- By:
- Publication type:
- Article
Clinical severity of Omicron subvariants BA.1, BA.2, and BA.5 in a population‐based cohort study in British Columbia, Canada.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28423
- By:
- Publication type:
- Article
An Elastic Net Regression Model for Identifying Long COVID Patients Using Health Administrative Data: A Population-Based Study.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 12, p. 1, doi. 10.1093/ofid/ofac640
- By:
- Publication type:
- Article
Impact of Current Opioid Agonist Therapy on Hepatitis C Virus Treatment Initiation Among People Who Use Drugs From the Direct-acting Antiviral (DAA) Era: A Population-Based Study.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 4, p. 575, doi. 10.1093/cid/ciab546
- By:
- Publication type:
- Article
Geographic concentration of SARS-CoV-2 cases by social determinants of health in metropolitan areas in Canada: a cross-sectional study.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2022, v. 6, n. 194, p. E195, doi. 10.1503/cmaj.211249
- By:
- Publication type:
- Article
Association Between Prescription Opioid Therapy for Noncancer Pain and Hepatitis C Virus Seroconversion.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 1, p. e2143050, doi. 10.1001/jamanetworkopen.2021.43050
- By:
- Publication type:
- Article
Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. 2037, doi. 10.1093/cid/ciab526
- By:
- Publication type:
- Article
Impact of COVID‐19‐related public health measures on HCV testing in British Columbia, Canada: An interrupted time series analysis.
- Published in:
- Liver International, 2021, v. 41, n. 12, p. 2849, doi. 10.1111/liv.15074
- By:
- Publication type:
- Article
Viral hepatitis C cascade of care: A population‐level comparison of immigrant and long‐term residents.
- Published in:
- Liver International, 2021, v. 41, n. 8, p. 1775, doi. 10.1111/liv.14840
- By:
- Publication type:
- Article
Addressing inequities in care on the path to eliminating hepatitis C in BC.
- Published in:
- British Columbia Medical Journal, 2021, v. 63, n. 6, p. 252
- By:
- Publication type:
- Article
Validating viral hepatitis B and C diagnosis codes: a retrospective analysis using Ontario's health administrative data.
- Published in:
- Canadian Journal of Public Health, 2021, v. 112, n. 3, p. 502, doi. 10.17269/s41997-020-00435-x
- By:
- Publication type:
- Article
Social vulnerability in persons with chronic hepatitis C virus infection is associated with a higher risk of prescription opioid use.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85283-6
- By:
- Publication type:
- Article
HCV reinfection rates after cure or spontaneous clearance among HIV‐infected and uninfected men who have sex with men.
- Published in:
- Liver International, 2021, v. 41, n. 3, p. 482, doi. 10.1111/liv.14762
- By:
- Publication type:
- Article
The impact of public coverage of newer hepatitis C medications on utilization, adherence, and costs in British Columbia.
- Published in:
- PLoS ONE, 2021, v. 16, n. 3, p. 1, doi. 10.1371/journal.pone.0247843
- By:
- Publication type:
- Article
Hospital Costs of Injection Drug Use in Florida.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 3, p. 499, doi. 10.1093/cid/ciaa823
- By:
- Publication type:
- Article
Association between markers of immune response at hospital admission and COVID‐19 disease severity and mortality: A meta‐analysis and meta‐regression.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 2, p. 1078, doi. 10.1002/jmv.26411
- By:
- Publication type:
- Article
Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019.
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0244575
- By:
- Publication type:
- Article
Quantifying the impact of COVID-19 control measures using a Bayesian model of physical distancing.
- Published in:
- PLoS Computational Biology, 2020, v. 16, n. 12, p. 1, doi. 10.1371/journal.pcbi.1008274
- By:
- Publication type:
- Article
Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population‐based cohort studies.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 12, p. 1419, doi. 10.1111/jvh.13373
- By:
- Publication type:
- Article
The Causal Effect of Opioid Agonist Treatment on Adherence to Direct-Acting Antiviral Treatment for Hepatitis C Virus.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 10, p. 1, doi. 10.1093/ofid/ofaa418
- By:
- Publication type:
- Article
Comparing direct acting antivirals for hepatitis C using observational data - Why and how?
- Published in:
- Pharmacology Research & Perspectives, 2020, v. 8, n. 5, p. 1, doi. 10.1002/prp2.650
- By:
- Publication type:
- Article
Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 9, p. 1, doi. 10.1093/ofid/ofaa347
- By:
- Publication type:
- Article
The impact of SVR from direct‐acting antiviral‐ and interferon‐based treatments for HCV on hepatocellular carcinoma risk.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 8, p. 781, doi. 10.1111/jvh.13295
- By:
- Publication type:
- Article
Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 5, p. e204192, doi. 10.1001/jamanetworkopen.2020.4192
- By:
- Publication type:
- Article
Loss to follow‐up: A significant barrier in the treatment cascade with direct‐acting therapies.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 3, p. 243, doi. 10.1111/jvh.13228
- By:
- Publication type:
- Article
Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 3, p. N.PAG, doi. 10.1093/ofid/ofaa055
- By:
- Publication type:
- Article
The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. 2261, doi. 10.1111/liv.14227
- By:
- Publication type:
- Article
Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 5, p. e193613, doi. 10.1001/jamanetworkopen.2019.3613
- By:
- Publication type:
- Article
Medical Information Commons to Support Learning Healthcare Systems: Examples From Canada.
- Published in:
- Journal of Law, Medicine & Ethics, 2019, v. 47, n. 1, p. 97, doi. 10.1177/1073110519840488
- By:
- Publication type:
- Article
Applying core theory and spatial analysis to identify hepatitis C virus infection "core areas" in British Columbia, Canada.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 3, p. 373, doi. 10.1111/jvh.13043
- By:
- Publication type:
- Article
Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk.
- Published in:
- Journal of Viral Hepatitis, 2018, v. 25, n. 12, p. 1481, doi. 10.1111/jvh.12977
- By:
- Publication type:
- Article
Decreasing Hepatitis C Incidence Among a Population With Repeated Tests: British Columbia, Canada, 1993-2011.
- Published in:
- American Journal of Public Health, 2015, v. 105, n. 8, p. 1604, doi. 10.2105/AJPH.2015.302591
- By:
- Publication type:
- Article
Education and resources for people affected by hepatitis C.
- Published in:
- British Columbia Medical Journal, 2015, v. 57, n. 1, p. 27
- By:
- Publication type:
- Article
Pre- and Postpandemic Estimates of 2009 Pandemic Influenza A(H1N1) Seroprotection to Inform Surveillance-Based Incidence, by Age, During the 2013-2014 Epidemic in Canada.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Pre- and Postpandemic Estimates of 2009 Pandemic Influenza A(H1N1) Seroprotection to Inform Surveillance-Based Incidence, by Age, During the 2013–2014 Epidemic in Canada.
- Published in:
- Journal of Infectious Diseases, 2015, v. 211, n. 1, p. 109, doi. 10.1093/infdis/jiu366
- By:
- Publication type:
- Article
Influenza A/Subtype and B/Lineage Effectiveness Estimates for the 2011-2012 Trivalent Vaccine: Cross-Season and Cross-Lineage Protection With Unchanged Vaccine.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0092153
- By:
- Publication type:
- Article
Randomized Controlled Ferret Study to Assess the Direct Impact of 2008–09 Trivalent Inactivated Influenza Vaccine on A(H1N1)pdm09 Disease Risk.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086555
- By:
- Publication type:
- Article
Understanding Suboptimal Influenza Vaccine Effectiveness Within the Agent, Host, and Environment Paradigm.
- Published in:
- 2013
- By:
- Publication type:
- Letter